Cytocares

About:

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

Website: http://www.cytocares.com

Top Investors: Shenzhen Capital Group, Tailong Investment, Jolmo Capital, Prosperico Ventures, Bossage Genetics

Description:

Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.

Total Funding Amount:

100M CNY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2015-12-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-05-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai